Hypertension A Companion to Braunwald`s Heart Disease 4th Edition

• Thoroughly covers new treatment guidelines related to recent research and the latest physiologic understanding for a wide range of patients with hypertension and related co-morbidities. 

• Includes new chapters on Hypertension in Women, Mineralocorticoid Receptor Antagonists, Exercise and Hypertension, and Telemedicine/Digital Health. 

• Contains new or expanded content on epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management. 

• Provides new chapter summaries and a new focus on clinical and actionable content using a streamlined, narrative format. 

• Covers behavior management and prevention as an integral part of hypertensive and pre-hypertensive treatment plans. 

• Highlights combination drug therapies and management of chronic complications of hypertension. 

• Offers expert guidance from worldwide experts in cardiology, endocrinology, and nephrology, and integrates the most recent guidelines from leading organizations around the world. 

• An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. 

Tentative pending approval from Dr Braunwald

SECTION I: EPIDEMIOLOGY

1. General Population and Global Cardiovascular Risk Prediction

2. Hypertension in Latin/Hispanic Population

3. Hypertension in East Asians and Native Hawaiians

4. Hypertension in South Asians

5. Hypertension in Women - NEW

SECTION II: PATHOPHYSIOLOGY

6. Pathogenesis of Hypertension

7. Genetics of Hypertension

8. Inflammation and Immunity in Hypertension

SECTION III: DIAGNOSIS AND EVALUATION

9. Environmental Factors Affecting Blood Pressure Development

10. Office Blood Pressure Measurement

11. Home Monitoring of Blood Pressure

12. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management

13. White Coat and Masked Hypertension

14. Secondary Hypertension: Renovascular Hypertension

15. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States

16. Secondary Hypertension: Pheochromocytoma

17. Secondary Hypertension: Sleep Disturbances including Sleep Apnea

18. Hypertension in Children: Diagnosis and Treatment

SECTION IV: RISK STRATIFICATION

19. Natural History of Untreated Hypertension

20. Isolated Systolic Hypertension

21. Assessment of Target Organ Damage

SECTION V: ANTIHYPERTENSIVE THERAPY

22. Diet and Blood Pressure

23. Diuretic Therapy

24. Peripheral Adrenergic Blockers

25. Renin Angiotensin Aldosterone System Blockers

26. Calcium Channel Blockers

27. Central Sympathetic Agents and Direct Vasodilators

28. Mineralocorticoid Receptor Antagonists – NEW

29. Use of Combination Therapies

30. Devices Therapies

31. Alternative/Complementary Medicine

SECTION VI: HYPERTENSION MANAGEMENT

32. Approach to Uncomplicated Primary Hypertension

33. Ischemic Heart Disease

34. Heart Failure

35. Kidney Disease including Dialysis

36. Transplant Hypertension

37. Obesity

38. Cerebrovascular Disease

39. Diabetes Mellitus

40. Dyslipidemia

SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS

41. Hypertension in Pregnancy

42. Hypertension in Older People

43. Hypertension in African Americans

44. Baroreceptor Dysfunction/Orthostatic Hypotension

45. Resistant Hypertension

46. Hypertension and the Perioperative Period

47. Aorta and Peripheral Arterial Disease in Hypertension

48. Hypertensive Emergencies

49. Exercise and Hypertension - NEW

SECTION VIII: OUTCOME TRIALS

50. Meta-Analyses of Hypertension Trials: The Blood Pressure Lowering Treatment Trialists’ Collaboration

SECTION IX: HYPERTENSION TREATMENT IN THE FUTURE

51. Team-Based Care for Hypertension Management

52. Understanding and Improving Medication Adherence

53. Telemedicine and Digital Health for Hypertension Management - NEW